Geben Sie ein Wort oder eine Phrase in einer beliebigen Sprache ein 👆
Sprache:
Übersetzung und Analyse von Wörtern durch künstliche Intelligenz
Auf dieser Seite erhalten Sie eine detaillierte Analyse eines Wortes oder einer Phrase mithilfe der besten heute verfügbaren Technologie der künstlichen Intelligenz:
- wie das Wort verwendet wird
- Häufigkeit der Nutzung
- es wird häufiger in mündlicher oder schriftlicher Rede verwendet
- Wortübersetzungsoptionen
- Anwendungsbeispiele (mehrere Phrasen mit Übersetzung)
- Etymologie
Bamberges-Marie disease - Übersetzung nach russisch
NEUROMUSCULAR DISEASE THAT IS CHARACTERIZED BY A SLOWLY PROGRESSIVE DEGENERATION OF THE MUSCLES OF THE FOOT, LOWER LEG, HAND AND FOREARM
Charcot-Marie-Tooth; Charcot marie tooth; Charcot-Marie-Tooth Disease; Charcot-marie-tooth disease; Charcot-Marie-Tooth disease, type 1; Charcot-Marie-Tooth disease, type 2; Cmt1a; AR-CMT2; Charcot-Marie Tooth Disease; Charcot-Marie-Tooth disease, type 4; Carcot marie tooth; Peroneal Muscular Atrophy; Hereditary sensorimotor neuropathy type 2; Hereditary sensory-motor neuropathy type 2; HSMN type 2; Peroneal muscular atrophy type 2; Charcot-Marie-Tooth disease (neuronal form); Charcot-Marie-Tooth disease type 2; Hereditary sensorimotor neuropathy type 1; HSMN type 1; Peroneal muscular atrophy type 1; Charcot-Marie-Tooth disease type 1; Hereditary motor and sensory neuropathy type 1; Charcot-Marie-Tooth disease type 1A; Charcot-Marie-Tooth disease type 1B; Charcot-Marie-Tooth disease type 1C; Charcot-Marie-Tooth disease type 2A; Charcot-Marie-Tooth disease type 2C; Charcot-Marie-Tooth disease type 2D; Charcot-Marie-Tooth disease type 4A; Charcot Marie Tooth disease deafness recessive type; Charcot-Marie-Tooth disease deafness recessive type; Charcot-Marie-Tooth disease type 4D; Charcot Marie tooth disease deafness dominant type; Charcot Marie Tooth disease deafness dominant type; Charcot-Marie-Tooth disease deafness dominant type; Charcot-Marie-Tooth disease and deafness deafness dominant type; Charcot-Marie-Tooth peroneal muscular atrophy X-linked; Charcot-Marie-Tooth disease, X-linked type 1; Charcot-Marie-Tooth disease, X-linked type 2, recessive; Charcot-Marie-Tooth disease, X-linked type 3, recessive; Charcot-Marie-Tooth disease, X-linked type 2 recessive; Charcot-Marie-Tooth disease, X-linked type 3 recessive; Charcot-Marie-Tooth peroneal muscular atrophy, X-linked; Charcot-Marie-Tooth disease with ptosis and parkinsonism; Charcot Marie Tooth type 1 aplasia cutis congenita; Charcot-Marie-Tooth type 1 aplasia cutis congenita; Charcot-Marie-Tooth disease type 1 aplasia cutis congenita; Motor sensory neuropathy type 1 aplasia cutis congenita; Charcot-Marie-Tooth syndrome; Peroneal Muscle Atropy; Charcot Marie Tooth disease; Cowchock Syndrome; Charcot-Marie-Tooth disease type 2B1; Charcot-Marie-Tooth disease type 2B2; Charcot-Marie-Tooth disease type 4B; Charcot-Marie-Tooth disease, neuronal, type A; Charcot-Marie-Tooth disease, neuronal, type B; Charcot-Marie-Tooth disease, neuronal, type D; Cowchock syndrome; Charcot Marie tooth disease deafness mental retardation; Charcot Marie tooth disease with deafness and mental retardation; Neuropathy, axonal motor-sensory with deafness and mental retardation; Charcot-Marie-Tooth disease, X-linked recessive, 4; Charcot-Marie-Tooth disease with deafness and mental retardation; Rosenberg-Chutorian syndrome; Charcot-Marie-Tooth disease, X-linked recessive type 5; Charcot-Marie-Tooth neuropathy; CMT2A; CMTD; Charcot-Marie-Tooth disease; Rosenberg Chutorian syndrome; Charcot-Marie-Tooth disease type 2A2; Charcot-Marie-Tooth disease type 2A1; Charcot-Marie-tooth disease; Charcot-Marie-Tooth disease type 1D; Charcot-Marie-Tooth disease type 1E; Charcot-Marie-Tooth disease type 2B; Charcot-Marie-Tooth disease type 1F; Charcot-Marie-Tooth disease type 2E; Charcot-Marie-Tooth disease type 2I; Charcot-Marie-Tooth disease type 2J; Charcot-Marie-Tooth disease type 4C; Charcot-Marie-Tooth disease type 4F; Charcot-Marie-Tooth disease type 4H; Charcot-Marie-Tooth disease type 4J; Peroneal muscular atrophy; Rosenberg–Chutorian syndrome; Charcot–Marie–Tooth disease, type 2; CMT5; CMT6; CMTDI; CMTRI; Charcot–Marie–Tooth syndrome type 1A; Charcot-Marie-Tooth syndrome type 1A; Charcot–Marie–Tooth disease, type 1; Charcot–Marie–Tooth disease, type 4; Charcot–Marie–Tooth disease 2B1; Charcot-Marie-Tooth disease 2B1; CMT disease
![Ankle-foot orthosis]]](https://commons.wikimedia.org/wiki/Special:FilePath/Charcot Marie Tooth CMT.jpg?width=200 "Ankle-foot orthosis]]")
![[[Denervation]] [[atrophy]] of type II [[muscle fibers]]](https://commons.wikimedia.org/wiki/Special:FilePath/Denervation atrophy - atp94 - intermed mag.jpg?width=200 "[[Denervation]] [[atrophy]] of type II [[muscle fibers]]")
![[[Chromosome 17]]](https://commons.wikimedia.org/wiki/Special:FilePath/Human male karyotpe high resolution - Chromosome 17 cropped.png?width=200 "[[Chromosome 17]]")
Bamberges-Marie disease
медицина
генерализованный остеофитоз
peroneal muscular atrophy
медицина
перонеальная мышечная атрофия
Charcot-Marie-Tooth disease
медицина
наследственная невральная амиотрофия
перонеальная мышечная атрофия
Definition
Мария Бургундская
(Marie de Bourgogne)
(13.2.1457, Брюссель, - 27.3.1482, Брюгге), дочь и наследница бургундского герцога Карла Смелого (См. Карл Смелый); унаследовала престол в январе 1477 после его гибели, однако часть Бургундского государства, в том числе Бургундское герцогство, перешло к французскому королю, а во владение Нидерландами (См. Нидерланды) М. Б. смогла вступить, лишь подписав "Великую привилегию" (См. Великая привилегия). В целях укрепления своей власти вступила в брак с Максимилианом Габсбургом (будущий император Максимилиан I), благодаря чему Габсбурги завладели Нидерландами.
Wikipedia
Charcot–Marie–Tooth disease
Charcot–Marie–Tooth disease (CMT) is a hereditary motor and sensory neuropathy of the peripheral nervous system characterized by progressive loss of muscle tissue and touch sensation across various parts of the body. This disease is the most commonly inherited neurological disorder, affecting about one in 2,500 people. It is named after those who classically described it: the Frenchman Jean-Martin Charcot (1825–1893), his pupil Pierre Marie (1853–1940), and the Briton Howard Henry Tooth (1856–1925).
There is no known cure. Care focuses on maintaining function. CMT was previously classified as a subtype of muscular dystrophy.
